Apr 16 |
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
|
Apr 12 |
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
|
Apr 11 |
PaxMedica shares soar 125% post-market on drug update
|
Apr 11 |
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission
|
Mar 13 |
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments
|
Jan 18 |
IBN Highlights PaxMedica's Video Release on Transformative ASD Study
|
Jan 17 |
PaxMedica on Promising Path to Address Unmet ASD Needs
|
Dec 22 |
PaxMedica Files 8-K Following Nasdaq Compliance Achievement
|
Dec 19 |
PaxMedica CEO Howard Weisman Sheds Light on Achievements for ASD Therapy Pipeline
|
Dec 12 |
PaxMedica Inc. Covered in H.C. Wainwright & Co. Research Report
|